The effect of suppressing discoidin domain receptor expression on keloid formation and proliferation 

Yuzhi Jiang1, Xin Xing2, Shuliang Lu

  • 1Shanghai Burn Institute, Ruijin Hospital; Shanghai Jiaotong University, Shanghai, P.R. China;

Abstract

Insights

Blocking discoidin domain receptor 1 (DDR1) signaling in keloid fibroblasts using gene therapy can inhibit keloid formation. This approach downregulates collagen production, improving scar quality and quantity for potential clinical use.

Area of Science:

  • Dermatology and Molecular Biology
  • Wound Healing and Scarring
  • Gene Therapy and Fibrosis

Background:

  • Discoidin domain receptors (DDRs) are tyrosine kinase receptors involved in collagen modulation in scar tissue.
  • Increased DDR1 expression is observed in keloid fibroblasts, suggesting a role in keloid pathogenesis.

Purpose of the Study:

  • To investigate the effect of blocking discoidin domain receptor 1 (DDR1) signaling in keloid fibroblasts.
  • To evaluate the potential of gene therapy using DDR1-antisense oligodeoxynucleotide (ASODN) to inhibit keloid formation and proliferation.

Main Methods:

  • Immunohistology and Western blot were used to assess DDR1 expression in keloid tissues and fibroblasts.
  • Keloid fibroblasts were treated in vitro with DDR1-ASODN via liposome encapsulation.
  • Northern blot and [3H] proline incorporation were employed to analyze collagen gene expression and extracellular matrix production.

Main Results:

  • DDR1 expression was significantly elevated in keloid tissues and fibroblasts compared to normal skin.
  • DDR1-ASODN treatment markedly downregulated DDR1, type I, and type III collagen gene expression and extracellular matrix production.
  • The ratio of type I to type III collagen was significantly improved in treated fibroblasts.

Conclusions:

  • Keloid fibroblasts exhibit higher DDR1 gene expression than normal dermal fibroblasts.
  • Downregulating DDR1 expression with ASODN can improve collagen quality and quantity.
  • This gene therapy approach shows potential for controlling fibrosis and keloid formation in clinical settings.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K